Skip to main content
Back to News

News From Around the System

UC Davis Health pauses Johnson & Johnson vaccine due to extremely rare side effect

UC Davis Health — April 13, 2021

UC Davis Health has paused all use of the Johnson & Johnson vaccine, following guidance from the CDC. This will not impact our ability to vaccinate thousands of people each day. The vaccines from Pfizer and Moderna are safe, and the risks of COVID-19 are still greater than not being…

UC Davis Medical Center

Longtime UC Irvine supporters donate $5 million for integrative cardiology

UCI Health — April 12, 2021

A $5 million gift to the University of California, Irvine from Linda and Mike Mussallem will support integrative cardiology care, training and research in the Susan Samueli Integrative Health Institute and initiate a UC system-wide health coaching program. “We are thrilled to receive this very generous gift,” said UCI Health…

New CAR T approach minimizes resistance, helps avoid relapse in non-Hodgkin's B-cell lymphoma

UCLA Health — April 9, 2021

LOS ANGELES — Early results from a new, pioneering chimeric antigen receptor (CAR) T cell immunotherapy trial led by researchers at the UCLA Jonsson Comprehensive Cancer Center found using a bilateral attack instead of the conventional single-target approach helps minimizes treatment resistance, resulting in long-lasting remission for people with non-Hodgkin's…

New remote patient-care technology assists patients using neuromodulation therapy

UC Davis Health — April 9, 2021

The Deep Brain Stimulation (DBS) Program at UC Davis Health has a new tool to treat patients receiving neuromodulation therapy for movement disorders. Abbott’s NeuroSphere Virtual Clinic is a first-of-its-kind remote patient care system. UC Davis Health is the first hospital in Northern California and among the first 10 in…

UC Davis Medical Center

Health Media Contacts

Find the best contact for health-related media inquiries.

View All Media Contacts